Related Experiment Video
Updated: Jul 1, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Candidate circulating biomarkers for the cardiovascular disease continuum
Olena Dotsenko1, Julia Chackathayil, Jeetesh V Patel
1Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, England.
Identifying new cardiac biomarkers is crucial for predicting cardiovascular events. This review covers promising plasma biomarkers like C-reactive protein and natriuretic peptides for improved risk stratification.
Area of Science:
- Cardiovascular Medicine
- Biomarker Research
- Atherothrombosis
Background:
- Traditional risk factors inadequately explain cardiovascular disease predisposition and treatment responses.
- Early identification and risk stratification of cardiovascular outcomes are research priorities.
- There is a need for novel biomarkers in atherothrombotic disease management.
Purpose of the Study:
- To review biomarker qualification principles for clinical practice.
- To provide an overview of targeted biomarker development in cardiovascular disease.
- To discuss promising plasma biomarkers for clinical risk assessment.
Main Methods:
- Review of epidemiological and clinical studies.
- Analysis of evidence for candidate plasma biomarkers.
- Discussion of biomarker qualification and clinical implementation.
Main Results:
- C-reactive protein, coagulation/inflammatory mediators, and natriuretic peptides show potential.
- These biomarkers can aid in risk stratification for cardiovascular events.
- Biomarker qualification principles guide clinical integration.
Conclusions:
- Novel plasma biomarkers are essential for enhancing cardiovascular risk assessment.
- Targeted biomarkers improve the stratification of individuals at risk.
- Further research supports the clinical utility of these biomarkers in atherothrombosis.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
